M-MLV Reverse Transcriptase, RNase H Minus
M-MLV Reverse Transcriptase, RNase H Minus - M (Molecular Biology) is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Shipping notes
Shipping notes
Details
Details
Product Information
Product description: M-MLV Reverse Transcriptase, RNase H Minus is an RNA-dependent DNA polymerase with no detectable RNase H activity. A point mutation in the RNase H domain increases the thermostablity of the enzyme and support greater cDNA yield of full-length transcripts than wild type M-MLV Reverse Transcriptase.
Source: Recombinant E.coli
Concentration: 200U/μL
Unit Definition: One unit is defined as the amount of enzyme required to catalyze the transfer of 1nmol of deoxynucleotides into acid-precipitable material in 10 minutes at 37℃.
Storage Buffer: 20mM Tris-HCl (pH7.5 at 25℃), 0.1mM EDTA, 200mM NaCl, 0.01% NP-40, 1mM DTT and 50% Glycerol.
Companion Product: 5X RT Reaction Buffer, Cat#ON-067, 250mM Tris-HCl (pH8.3 at 25℃), 375mM KCl, 15mM MgCl2, 50mM DTT.
Key points of operation
- Before the first-strand Synthesis of DNA, heat the primer (about 0.5μg) and template (up to 2μg) to 70℃ for 5min to melt secondary structure within the template. Cool the tube on ice to prevent secondary structure from reforming.
- Add the following components to the annealed primer/template:
- Incubate for 60min at 42℃.
Security Information
Storage Conditions: -20℃
Quality Assurance: Free of endonuclease, exonuclease, Nickase and RNase activities.
Physical Purity: >95% by SDS-PAGE.
Reference
1. Yu Chen, Weiguo Xu, Qining Sun, Biotechnol Lett. 31, 1051–1057 (2009).
2. Shufeng Liu, Stephen P. Goff, et al. FEBS Letters. 580, 1497-1501(2006).
3. Monica J. Roth, Naoko Tanese, and Stephen P. Goff, The Journal Of Biological Chemistry. 260, 9326-9335(1985).
Specifications
Specifications
-
Catalog No.ON-047
-
SourceRecombinant E.coli
-
Purity>95% by SDS-PAGE
-
Storage Condition-20℃
Documentation
Documentation
Product Information
Product description: M-MLV Reverse Transcriptase, RNase H Minus is an RNA-dependent DNA polymerase with no detectable RNase H activity. A point mutation in the RNase H domain increases the thermostablity of the enzyme and support greater cDNA yield of full-length transcripts than wild type M-MLV Reverse Transcriptase.
Source: Recombinant E.coli
Concentration: 200U/μL
Unit Definition: One unit is defined as the amount of enzyme required to catalyze the transfer of 1nmol of deoxynucleotides into acid-precipitable material in 10 minutes at 37℃.
Storage Buffer: 20mM Tris-HCl (pH7.5 at 25℃), 0.1mM EDTA, 200mM NaCl, 0.01% NP-40, 1mM DTT and 50% Glycerol.
Companion Product: 5X RT Reaction Buffer, Cat#ON-067, 250mM Tris-HCl (pH8.3 at 25℃), 375mM KCl, 15mM MgCl2, 50mM DTT.
Key points of operation
- Before the first-strand Synthesis of DNA, heat the primer (about 0.5μg) and template (up to 2μg) to 70℃ for 5min to melt secondary structure within the template. Cool the tube on ice to prevent secondary structure from reforming.
- Add the following components to the annealed primer/template:
- Incubate for 60min at 42℃.
Security Information
Storage Conditions: -20℃
Quality Assurance: Free of endonuclease, exonuclease, Nickase and RNase activities.
Physical Purity: >95% by SDS-PAGE.
Reference
1. Yu Chen, Weiguo Xu, Qining Sun, Biotechnol Lett. 31, 1051–1057 (2009).
2. Shufeng Liu, Stephen P. Goff, et al. FEBS Letters. 580, 1497-1501(2006).
3. Monica J. Roth, Naoko Tanese, and Stephen P. Goff, The Journal Of Biological Chemistry. 260, 9326-9335(1985).
-
Catalog No.ON-047
-
SourceRecombinant E.coli
-
Purity>95% by SDS-PAGE
-
Storage Condition-20℃
Why choose Hongene?
Trusted Partner in Nucleic Acid
Integrated Supply & Commercial Scale
With 26+ years of expertise, we control a secure supply chain for RNA raw materials and provide reliable GMP-grade oligo synthesis from research to commercial kilogram-scale production.
Proprietary Technology & IP
Our proprietary Chemoenzymatic Ligation Platform combines chemical andenzymatic methods, enabling high-putity, cost-effective, and large-scale production of RNA-based therapeutics.
Rigorous Quality
We implement multiple stringent QC steps, maintain ISO certifications, and ensure >99% batch-to-batch consistency, reducing scale-up and PPQ risks.
Manufacturing Scalability
Hongene operates 1.67 million sq. ft Oligonucleotide Manufacturing Facility, with advanced equipments including multiple OligoPilot™ and OligoProcess™ synthesizers (10-1800 mmol). 48 flexible production lines enable one-stop seamless scaling-up of API production from gram-level to tons and acheive high purity of 98%, meeting NMPA, FDA, and EMA standards.
Global Business Network
Our products and services reach over 40 countries and regions, supporting around 3,000 clients worldwide.

